Non-equivalence of digoxin tablets.
作者信息
Reissell P, Manninen V, Ojala K, Karjalainen J
出版信息
Ann Clin Res. 1974;6(0):suppl 11:4-8.
PMID:4853359
Abstract
摘要
相似文献
1
Non-equivalence of digoxin tablets.
Ann Clin Res. 1974;6(0):suppl 11:4-8.
2
Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.
Ann Clin Res. 1973 Apr;5(2):87-90.
3
Non-equivalent digoxin tablets.非等效地高辛片剂。
Ann Clin Res. 1974 Jun;6(3):132-6.
4
[Clinical equivalence between digoxin tablets?].[地高辛片之间的临床等效性？]
Lakartidningen. 1973 Feb 7;70(6):469-70.
5
Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy.地高辛生物利用度及药代动力学与心脏治疗相关性的评估。
Am Heart J. 1974 Aug;88(2):133-8. doi: 10.1016/0002-8703(74)90001-5.
6
Bioavailability of digoxin in man after oral administration of preparations with different dissolution rate.
Acta Pharmacol Toxicol (Copenh). 1977;40 Suppl 3:1-48.
7
Variation in biologic availability of digoxin from four preparations.四种制剂中地高辛生物利用度的差异。
N Engl J Med. 1971 Dec 9;285(24):1344-7. doi: 10.1056/NEJM197112092852403.
8
Bioavailability of digoxin tablets.
Pharmacol Rev. 1973 Jun;25(2):229-37.
9
Evaluation of digoxin bioavailability in single-dose studies.
N Engl J Med. 1973 Sep 27;289(13):651-4. doi: 10.1056/NEJM197309272891302.
10
Dissimilarities of digoxin.
N Engl J Med. 1971 Dec 9;285(24):1376-7. doi: 10.1056/NEJM197112092852414.
引用本文的文献
1
Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.使用仿制药不足的经济后果：来自医疗补助计划的证据及对处方药福利计划的启示
Health Serv Res. 2003 Aug;38(4):1051-63. doi: 10.1111/1475-6773.00162.
2
The relationship between cardiotoxicity and plasma digoxin concentration in conscious dogs.清醒犬心脏毒性与血浆地高辛浓度之间的关系。
Br J Pharmacol. 1976 May;57(1):23-7. doi: 10.1111/j.1476-5381.1976.tb07652.x.
3
Bioavailability of drugs: the digoxin dilemma.药物的生物利用度：地高辛的困境。
Clin Pharmacokinet. 1976;1(1):36-51. doi: 10.2165/00003088-197601010-00004.
Zotero 插件